Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors

Journal of Biological Chemistry

Volumn 288, Issue 45, 2013, Pages 32517-32527

  Marzoq, Aseel J ^a   Giese, Nathalia ^b   Hoheisel, Jörg D ^a   Alhamdani, Mohamed Saiel Saeed ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC ACTIVITY; MOLECULAR CHANGES; NEO-VASCULARIZATION; PANCREATIC CANCERS; PRIME FACTORS; PROINFLAMMATORY; SERUM-FREE MEDIUM; STELLATE CELLS;

ACTIVATION ANALYSIS; ANTIBODIES; BODY FLUIDS; CYTOLOGY; DISEASES;

CELLS;

ALPHA SMOOTH MUSCLE ACTIN; CORTACTIN; CYTOKERATIN 19; FIBROBLAST GROWTH FACTOR 2; FILAMIN A; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; SOMATOMEDIN C; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS;

ANTIBODY MICROARRAY; MICROARRAY; PANCREATIC CANCER; PANCREATIC STELLATE CELL; PROTEOMICS; STROMAL CELL; TUMOR NECROSIS FACTOR (TNF);

APOPTOSIS; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; HEPATIC STELLATE CELLS; HUMANS; INFLAMMATION MEDIATORS; PANCREATIC NEOPLASMS; PROTEOME;

EID: 84887446281     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.488387     Document Type: Article

References (64)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009) Cancer statistics, 2009. CA-Cancer J. Clin. 59, 225-249
2. Li, D., Xie, K., Wolff, R., and Abbruzzese, J. L. (2004) Pancreatic cancer. Lancet 363, 1049-1057
3. Matsubara, J., Ono, M., Honda, K., Negishi, A., Ueno, H., Okusaka, T., Furuse, J., Furuta, K., Sugiyama, E., Saito, Y., Kaniwa, N., Sawada, J., Shoji, A., Sakuma, T., Chiba, T., Saijo, N., Hirohashi, S., and Yamada, T. (2010) Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. Mol. Cell. Proteomics 9, 695-704
4. Yokoyama, Y., Nimura, Y., and Nagino, M. (2009) Advances in the treatment of pancreatic cancer. Limitations of surgery and evaluation of new therapeutic strategies. Surg. Today 39, 466-475
5. Fidler, I. J. (2002) The organ microenvironment and cancer metastasis. Differentiation 70, 498-505
6. Erkan, M., Reiser-Erkan, C., Michalski, C. W., and Kleeff, J. (2010) Tumor microenvironment and progression of pancreatic cancer. Exp. Oncol. 32, 128-131
7. Edmonds, C., and Cengel, K. A. (2008) Tumor-stroma interactions in pancreatic cancer. Will this SPARC prove a raging fire? Cancer Biol. Ther. 7, 1816-1817
8. Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., Ji, B., Evans, D. B., and Logsdon, C. D. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68, 918-926
9. Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., and Goggins, M. (2007) Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J. Clin. Oncol. 25, 319-325
10. Liotta, L. A., and Kohn, E. C. (2001) The microenvironment of the tumour- host interface. Nature 411, 375-379
11. Mahadevan, D., and Von Hoff, D. D. (2007) Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 6, 1186-1197
12. Omary, M. B., Lugea, A., Lowe, A. W., and Pandol, S. J. (2007) The pancreatic stellate cell. A star on the rise in pancreatic diseases. J. Clin. Invest. 117, 50-59
13. Apte, M. V., Haber, P. S., Applegate, T. L., Norton, I. D., McCaughan, G. W., Korsten, M. A., Pirola, R. C., and Wilson, J. S. (1998) Periacinar stellate shaped cells in rat pancreas. Identification, isolation, and culture. Gut 43, 128-133
14. Bachem, M. G., Schünemann, M., Ramadani, M., Siech, M., Beger, H., Buck, A., Zhou, S., Schmid-Kotsas, A., and Adler, G. (2005) Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907-921
15. Masamune, A., Watanabe, T., Kikuta, K., and Shimosegawa, T. (2009) Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 7, S48-54
16. Mews, P., Phillips, P., Fahmy, R., Korsten, M., Pirola, R., Wilson, J., and Apte, M. (2002) Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 50, 535-541
17. Bachem, M. G., Zhou, S., Buck, K., Schneiderhan, W., and Siech, M. (2008) Pancreatic stellate cells. Role in pancreas cancer. Langenbecks Arch. Surg. 393, 891-900
18. Shimizu, K. (2008) Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J. Gastroenterol. 43, 823-832
19. Bachem, M. G., Schneider, E., Gross, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grünert, A., and Adler, G. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115, 421-432
20. Masamune, A., Sakai, Y., Kikuta, K., Satoh, M., Satoh, A., and Shimosegawa, T. (2002) Activated rat pancreatic stellate cells express intercellular adhesion molecule-1 (ICAM-1) in vitro. Pancreas 25, 78-85
21. Dunér, S., Lopatko Lindman, J., Ansari, D., Gundewar, C., and Andersson, R. (2010) Pancreatic cancer. The role of pancreatic stellate cells in tumor progression. Pancreatology 10, 673-681
22. Caruso, J. A., Hunt, K. K., and Keyomarsi, K. (2010) The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. Cancer Res. 70, 7125-7136
23. Vonlaufen, A., Joshi, S., Qu, C., Phillips, P. A., Xu, Z., Parker, N. R., Toi, C. S., Pirola, R. C., Wilson, J. S., Goldstein, D., and Apte, M. V. (2008) Pancreatic stellate cells. Partners in crime with pancreatic cancer cells. Cancer Res. 68, 2085-2093
24. Schneider, E., Schmid-Kotsas, A., Zhao, J., Weidenbach, H., Schmid, R. M., Menke, A., Adler, G., Waltenberger, J., Grünert, A., and Bachem, M. G. (2001) Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am. J. Physiol. Cell Physiol. 281, C532-C543
25. Wehr, A. Y., Furth, E. E., Sangar, V., Blair, I. A., and Yu, K. H. (2011) Analysis of the human pancreatic stellate cell secreted proteome. Pancreas 40, 557-566
26. Paulo, J. A., Urrutia, R., Banks, P. A., Conwell, D. L., and Steen, H. (2011) Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). J. Proteomics 75, 708-717
27. Paulo, J. A., Urrutia, R., Banks, P. A., Conwell, D. L., and Steen, H. (2011) Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs. nonproliferating cell states. J. Proteome Res. 10, 4835-4844
28. Alhamdani, M. S., Youns, M., Buchholz, M., Gress, T. M., Beckers, M. C., Maréchal, D., Bauer, A., Schröder, C., and Hoheisel, J. D. (2012) Immunoassay- based proteome profiling of 24 pancreatic cancer cell lines. J. Proteomics 75, 3747-3759
29. Alhamdani, M. S., Schröder, C., and Hoheisel, J. D. (2010) Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Proteomics 10, 3203-3207
30. Schröder, C., Alhamdani, M. S., Fellenberg, K., Bauer, A., Jacob, A., and Hoheisel, J. D. (2011) Robust protein profiling with complex antibody microarrays in a dual-colour mode. Methods Mol. Biol. 785, 203-221
31. Jesnowski, R., Fürst, D., Ringel, J., Chen, Y., Schrödel, A., Kleeff, J., Kolb, A., Schareck, W. D., and Löhr, M. (2005) Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis. Deactivation is induced by Matrigel and N-acetylcysteine. Lab. Invest. 85, 1276-1291
32. Alhamdani, M. S., Schröder, C., Werner, J., Giese, N., Bauer, A., and Hoheisel, J. D. (2010) Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. J. Proteome Res. 9, 963-971
33. Schröder, C., Jacob, A., Tonack, S., Radon, T. P., Sill, M., Zucknick, M., Rüffer, S., Costello, E., Neoptolemos, J. P., Crnogorac-Jurcevic, T., Bauer, A., Fellenberg, K., and Hoheisel, J. D. (2010) Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol. Cell. Proteomics 9, 1271-1280
34. Cathcart, R., Schwiers, E., and Ames, B. N. (1984) Detection of picomole levels of lipid hydroperoxides using a dichlorofluorescein fluorescent assay. Methods Enzymol. 105, 352-358
35. Erkan, M., Kleeff, J., Esposito, I., Giese, T., Ketterer, K., Büchler, M. W., Giese, N. A., and Friess, H. (2005) Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24, 4421-4432
36. Ritchie, M. E., Silver, J., Oshlack, A., Holmes, M., Diyagama, D., Holloway, A., and Smyth, G. K. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23, 2700-2707
37. Smyth, G. K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3
38. Martin, B., Chadwick, W., Yi, T., Park, S. S., Lu, D., Ni, B., Gadkaree, S., Farhang, K., Becker, K. G., and Maudsley, S. (2012) VENNTURE. A novel Venn diagram investigational tool for multiple pharmacological dataset analysis. PloS ONE 7, e36911
39. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., Jensen, L. J., and von Mering, C. (2011) The STRING database in 2011. Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561-568
40. Erkan, M., Adler, G., Apte, M. V., Bachem, M. G., Buchholz, M., Detlefsen, S., Esposito, I., Friess, H., Gress, T. M., Habisch, H. J., Hwang, R. F., Jaster, R., Kleeff, J., Klöppel, G., Kordes, C., Logsdon, C. D., Masamune, A., Michalski, C. W., Oh, J., Phillips, P. A., Pinzani, M., Reiser-Erkan, C., Tsukamoto, H., and Wilson, J. (2012) StellaTUM. Current consensus and discussion on pancreatic stellate cell research. Gut 61, 172-178
41. Adamson, G. M., and Billings, R. E. (1992) Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch. Biochem. Biophys. 294, 223-229
42. Masamune, A., Watanabe, T., Kikuta, K., Satoh, K., and Shimosegawa, T. (2008) NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G99-G108
43. Lowenfels, A. B., and Maisonneuve, P. (2005) Risk factors for pancreatic cancer. J. Cell. Biochem. 95, 649-656
44. Poch, B., Lotspeich, E., Ramadani, M., Gansauge, S., Beger, H. G., and Gansauge, F. (2007) Systemic immune dysfunction in pancreatic cancer patients. Langenbecks Arch. Surg. 392, 353-358
45. Zhou, G., Niu, L., Chiu, D., He, L., and Xu, K. (2012) Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Biotechnol. Lett. 34, 1235-1241
46. Karayiannakis, A. J., Syrigos, K. N., Polychronidis, A., Pitiakoudis, M., Bounovas, A., and Simopoulos, K. (2001) Serum levels of tumor necrosis factor-α and nutritional status in pancreatic cancer patients. Anticancer Res. 21, 1355-1358
47. Balkwill, F. (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13, 135-141
48. Reichenbach, V., Ros, J., Fernández-Varo, G., Casals, G., Melgar-Lesmes, P., Campos, T., Makriyannis, A., Morales-Ruiz, M., and Jiménez, W. (2012) Prevention of fibrosis progression in CCl4-treated rats. Role of the hepatic endocannabinoid and apelin systems. J. Pharmacol. Exp. Ther. 340, 629-637
49. Lin, Y. J., Lai, M. D., Lei, H. Y., and Wing, L. Y. (2006) Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147, 1278-1286
50. Zeh, H. J., Winikoff, S., Landsittel, D. P., Gorelik, E., Marrangoni, A. M., Velikokhatnaya, L., Winans, M. T., Lee, K., Moser, A., Bartlett, D., Lotze, M. T., Siegfried, J. M., Whitcomb, D., Papacristou, G., Slivka, A., Bigbee, W. L., and Lokshin, A. E. (2005) Multianalyte profiling of serum cytokines for detection of pancreatic cancer. Cancer Biomark. 1, 259-269
51. Epstein, R. J., Hendricks, R. L., and Stulting, R. D. (1990) Interleukin-2 induces corneal neovascularization in A/J mice. Cornea 9, 318-323
52. Yang, F., Dou, H. L., Ma, Z., Li, Y. L., Lu, X. R., Wang, X., and He, P. P. (2010) Serum inflammatory factors in patients with idiopathic choroidal neovascularization. Ocular Immunol. Inflamm. 18, 390-394
53. Wara, A. K., Foo, S., Croce, K., Sun, X., Icli, B., Tesmenitsky, Y., Esen, F., Lee, J. S., Subramaniam, M., Spelsberg, T. C., Lev, E. I., Leshem-Lev, D., Pande, R. L., Creager, M. A., Rosenzweig, A., and Feinberg, M. W. (2011) TGF-β1 signaling and Kruppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization. Blood 118, 6450-6460
54. Shi, W., Liu, J., Li, M., Gao, H., and Wang, T. (2010) Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors. Curr. Eye Res. 35, 967-977
55. Tian, X., Chen, G., Zhou, S., Henne-Bruns, D., Bachem, M., and Kornmann, M. (2012) Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression. Hepatogastroenterology 59, 1604-1608
56. Li, R., Hou, J., Xu, Q., Liu, Q. J., Shen, Y. J., Rodin, G., and Li, M. (2012) High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line. Metab. Brain Dis. 27, 91-100
57. Mroczko, B., Groblewska, M., Gryko, M., Kedra, B., and Szmitkowski, M. (2010) Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J. Clin. Lab. Anal. 24, 256-261
58. Tomlins, C., and Storey, A. (2010) Cutaneous HPV5 E6 causes increased expression of osteoprotegerin and interleukin 6 which contribute to evasion of UV-induced apoptosis. Carcinogenesis 31, 2155-2164
59. Law, H. K., Tu, W., Liu, E., and Lau, Y. L. (2008) Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6. BMC Immunol. 9, 74
60. Campbell, V., and Lynch, M. A. (2000) The role of ceramide in the modulation of intracellular Ca2+ levels by interleukin 1 β in rat cortical synaptosomes. Cytokine 12, 487-490
61. Hill, H. R., Augustine, N. H., and Jaffe, H. S. (1991) Human recombinant interferon γ enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J. Exp. Med. 173, 767-770
62. Mahali, S., Raviprakash, N., Raghavendra, P. B., and Manna, S. K. (2011) Advanced glycation end products (AGEs) induce apoptosis via a novel pathway. Involvement of Ca2+ mediated by interleukin-8 protein. J. Biol. Chem. 286, 34903-34913
63. Adebanjo, O. A., Moonga, B. S., Yamate, T., Sun, L., Minkin, C., Abe, E., and Zaidi, M. (1998) Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption. J. Cell Biol. 142, 1347-1356
64. Hajnóczky, G., Davies, E., and Madesh, M. (2003) Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun. 304, 445-454